Randomized Clinical Trials in Gastrointestinal Stromal Tumors

Peter A. Learn, Jason K. Sicklick, Ronald P. DeMatteo*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Gastrointestinal (GI) stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract, constituting 80% of all GI mesenchymal tumors and approximately 20% of all small bowel malignancies, excluding lymphomas. This article provides a summary of recent randomized clinical trials of these tumors.

Original languageEnglish
Pages (from-to)101-113
Number of pages13
JournalSurgical Oncology Clinics of North America
Issue number1
StatePublished - Jan 2010
Externally publishedYes


  • Disease-free survival
  • Gastrointestinal stromal tumor
  • Recurrence-free survival


Dive into the research topics of 'Randomized Clinical Trials in Gastrointestinal Stromal Tumors'. Together they form a unique fingerprint.

Cite this